TrimRx's Blog

Ozempic longevity data shows cardiovascular benefits beyond weight loss, reducing major cardiac events by 20% in trials. Here’s what the research means

Ozempic and Alzheimers research shows GLP-1 agonists may reduce neuroinflammation and amyloid plaque formation—early trials suggest 20-48% cognitive

Ozempic doesn’t directly treat nicotine addiction, but emerging data shows GLP-1 agonists may reduce addictive behaviors through dopamine pathway

Ozempic doesn’t cause chemical addiction, but dependency patterns emerge. Learn safe discontinuation protocols, rebound risks, and medically-supervised

Emerging research shows GLP-1 medications like Ozempic may reduce alcohol cravings through dopamine modulation in reward pathways — here’s what patients

Emerging reports link Ozempic and GLP-1 medications to compulsive gambling behaviors. Learn the biological mechanism, risk factors, and what to watch for.

Ozempic compulsive shopping links to dopamine pathway disruption affecting impulse control. Learn mechanisms, risk factors, and clinical management

Semaglutide doesn’t directly cause social anxiety, but rapid weight loss and blood sugar shifts can influence mood and confidence during GLP-1 therapy.

Ozempic shows protective signals against Parkinson’s in early research, but GLP-1 therapy isn’t a prevention tool. Understand the data, mechanism, and